Berlin Chemie AG secures contract for Pharmaceutical Products - Completion of a non -exclusive discount agreement according to * 130a Abs 8 SGB V for the active ingredient fluticason vilanterol, ATC R03AK10 for the time 01022023 - 31012025

Germany, Jan. 30 -- Germany based Berlin Chemie AG has secured contract from DAK-Gesundheit for Pharmaceutical Products - Completion of a non -exclusive discount agreement according to * 130a Abs 8 SGB V for the active ingredient fluticason vilanterol, ATC R03AK10 for the time 01022023 - 31012025. The value of the contract is not disclosed.

Published by HT Digital Content Services with permission from Pivotal Sources....